文献速递产科母胎医学

钙补充预防子痫前期:对荟萃分析证据的挑战

Calcium supplementation for the prevention of pre-eclampsia: Challenging the evidence from meta-analyses.
PubMed 文献 · BJOG · 2024-02-01

该研究对Cochrane系统评价和荟萃分析中关于高剂量钙补充(至少1克/天)降低子痫前期风险的结论进行敏感性分析,发现三项最大研究(占88%样本)的汇总RR为0.92(95%CI 0.80-1.06),无显著异质性(I²=0);纳入较小研究后RR降至0.45,异质性增至70%,提示仅关注随机效应均值具有误导性。

要点

  • 三项最大研究占88%样本,汇总RR 0.92(95%CI 0.80-1.06),无显著异质性(I²=0)
  • 纳入较小研究后汇总RR降至0.45,异质性I²升至70%
  • 在存在显著异质性时,聚焦随机效应荟萃分析的均值具有高度误导性

核心结论

  • 在评估钙补充对子痫前期风险的影响时,存在显著异质性情况下,仅关注随机效应荟萃分析的均值具有高度误导性。

研究设计与样本

  • 对Cochrane系统评价和荟萃分析中评估高剂量钙补充(至少1克/天)降低子痫前期风险的试验数据进行敏感性分析。
  • Cochrane系统评价和荟萃分析纳入13项试验,共15730名女性。

主要发现

  • 随机效应荟萃分析得出平均风险比(RR,钙剂/安慰剂)为0.45(95%CI 0.31-0.65;P<0.0001)。
  • 三项最大研究占总招募人数的13815人(88%),平均RR为0.92(95%CI 0.80-1.06),研究间无显著异质性(I²=0)。
  • 纳入较小研究后,平均RR降至0.45,I²增至70%。

关键数值与推荐

  • 高剂量钙补充定义为至少1克/天。
  • 三项最大研究平均RR 0.92(95%CI 0.80-1.06),I²=0。
  • 全部研究随机效应荟萃分析平均RR 0.45(95%CI 0.31-0.65;P<0.0001),I²=70%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the validity of the conclusion from Cochrane reviews and meta-analyses that treatment with calcium supplementation during pregnancy reduces the risk for pre-eclampsia by 55%, which has been influential in international guidelines and future research. DESIGN: Sensitivity analysis of data from Cochrane reviews of trials evaluating high-dose calcium supplementation (of at least 1 g/day) for reduction of pre-eclampsia risk. SETTING: Systematic review and meta-analysis. POPULATION: The Cochrane reviews and meta-analyses included 13 trials enrolling a total of 15 730 women. Random-effects meta-analysis of these studies resulted in a mean risk ratio (RR, calcium/placebo) of 0.45 (95% confidence interval [CI] 0.31-0.65; p < 0.0001). METHODS: We carried out a sensitivity analysis of evidence from the relevant Cochrane review, to examine the impact of study size. MAIN OUTCOME MEASURES: pre-eclampsia. RESULTS: In the three largest studies, accounting for 13 815 (88%) of total recruitment, mean RR was 0.92 (95% CI 0.80-1.06) and there was no evidence of heterogeneity between studies (I2 = 0). With inclusion of the smaller studies, mean RR decreased to 0.45 and I2 increased to 70%. CONCLUSIONS: In assessment of the effect of calcium supplementation on pre-eclampsia risk, the naive focus on the mean of the random-effects meta-analysis in the presence of substantial heterogeneity is highly misleading.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Wright D, Wright A, Magee LA, et al. Calcium supplementation for the prevention of pre-eclampsia: Challenging the evidence from meta-analyses. BJOG. 2024. PMID: 38302677. doi:10.1111/1471-0528.17769

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。